203 related articles for article (PubMed ID: 16116682)
1. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation.
De Benedictis FM; Del Giudice MM; Vetrella M; Tressanti F; Tronci A; Testi R; Dasic G;
J Asthma; 2005 Jun; 42(5):331-6. PubMed ID: 16116682
[TBL] [Abstract][Full Text] [Related]
2. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
Agertoft L; Pedersen S
J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
[TBL] [Abstract][Full Text] [Related]
5. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
Ferguson AC; Spier S; Manjra A; Versteegh FG; Mark S; Zhang P
J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma.
Ringdal N; Chuchalin A; Chovan L; Tudoric N; Maggi E; Whitehead PJ;
Respir Med; 2002 Nov; 96(11):851-61. PubMed ID: 12418582
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ; Clark DJ; McFarlane LC
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[TBL] [Abstract][Full Text] [Related]
9. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.
Adams N; Lasserson TJ; Cates CJ; Jones PW
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD002310. PubMed ID: 17943772
[TBL] [Abstract][Full Text] [Related]
10. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.
Ayres JG; Bateman ED; Lundbäck B; Harris TA
Eur Respir J; 1995 Apr; 8(4):579-86. PubMed ID: 7664857
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma.
Jenkins C; Woolcock AJ; Saarelainen P; Lundback B; James MH
Respir Med; 2000 Jul; 94(7):715-23. PubMed ID: 10926345
[TBL] [Abstract][Full Text] [Related]
13. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
[TBL] [Abstract][Full Text] [Related]
15. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
Cetinkaya F; Kayiran P; Memioglu N; Tarim OF; Eren N; Erdem E
Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the clinical efficacy and the safety of salmeterol/fluticasone propionate accuhaler compared to budesonide turbuhalar in the control of adult asthma].
Zhong NS; Zheng JP; Cai BQ; Xie CM; Sun TY; Wang DQ; Lin YP; Chen BY; Tao JJ; Kang J; Li Q; Xu YP; Zhou X; Guo XJ; Chen XD; Yin KS; Zhang DP; Zhou JY; Shen HH; Qiu C; Feng YL; Xiao BR
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):233-7. PubMed ID: 15854431
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.
Karakoç F; Karadag B; Kut A; Ersu R; Bakaç S; Cebeci D; Dagli E
J Asthma; 2001 May; 38(3):229-37. PubMed ID: 11392363
[TBL] [Abstract][Full Text] [Related]
19. Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study.
Demirca BP; Cagan H; Kiykim A; Arig U; Arpa M; Tulunay A; Ozen A; Karakoc-Aydiner E; Baris S; Barlan IB
Respir Med; 2015 Sep; 109(9):1120-5. PubMed ID: 26216378
[TBL] [Abstract][Full Text] [Related]
20. Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic as efficacious as nebulized budesonide in adult asthmatics?
O'Reilly JF; Weir DC; Banham S; Basran GS; Boyd G; Patel KR
Respir Med; 1998 Jan; 92(1):111-7. PubMed ID: 9519234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
